These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
92 related items for PubMed ID: 16983342
21. Proteomic approach to the identification of novel delta-lactoferrin target genes: Characterization of DcpS, an mRNA scavenger decapping enzyme. Mariller C, Hardivillé S, Hoedt E, Benaïssa M, Mazurier J, Pierce A. Biochimie; 2009 Jan; 91(1):109-22. PubMed ID: 18725266 [Abstract] [Full Text] [Related]
22. Involvement of the c-jun N-terminal kinases JNK1 and JNK2 in complement-mediated cell death. Gancz D, Donin N, Fishelson Z. Mol Immunol; 2009 Dec; 47(2-3):310-7. PubMed ID: 19864026 [Abstract] [Full Text] [Related]
23. [Detection of CCAAT/enhancer binding protein alpha gene mutations in acute myeloid leukemia]. Zhao JM, Wang HW, Xu ZF, Zhu L, Bai B, Ge XY. Zhonghua Xue Ye Xue Za Zhi; 2005 May; 26(5):299-302. PubMed ID: 15949295 [Abstract] [Full Text] [Related]
24. Inhibition of CCAAT/enhancer binding protein family DNA binding in mouse epidermis prevents and regresses papillomas. Oh WJ, Rishi V, Orosz A, Gerdes MJ, Vinson C. Cancer Res; 2007 Feb 15; 67(4):1867-76. PubMed ID: 17308129 [Abstract] [Full Text] [Related]
25. Hypoxia down-regulates CCAAT/enhancer binding protein-alpha expression in breast cancer cells. Seifeddine R, Dreiem A, Blanc E, Fulchignoni-Lataud MC, Le Frère Belda MA, Lecuru F, Mayi TH, Mazure N, Favaudon V, Massaad C, Barouki R, Massaad-Massade L. Cancer Res; 2008 Apr 01; 68(7):2158-65. PubMed ID: 18381421 [Abstract] [Full Text] [Related]
26. IL-1 beta induces urokinase-plasminogen activator expression and cell migration through PKC alpha, JNK1/2, and NF-kappaB in A549 cells. Cheng CY, Hsieh HL, Sun CC, Lin CC, Luo SF, Yang CM. J Cell Physiol; 2009 Apr 01; 219(1):183-93. PubMed ID: 19097143 [Abstract] [Full Text] [Related]
27. Essential role of C/EBPalpha in G-CSF-induced transcriptional activation and chromatin modification of myeloid-specific genes. Iida S, Watanabe-Fukunaga R, Nagata S, Fukunaga R. Genes Cells; 2008 Apr 01; 13(4):313-27. PubMed ID: 18363963 [Abstract] [Full Text] [Related]
28. C/EBPalpha in leukemogenesis: a matter of being in the right place with the right signals. Castilla LH. Cancer Cell; 2008 Apr 01; 13(4):289-91. PubMed ID: 18394549 [Abstract] [Full Text] [Related]
29. Expression of C/EBPalpha and C/EBPbeta in glial cells in vitro after inducing glial activation by different stimuli. Pérez-Capote K, Saura J, Serratosa J, Solà C. Neurosci Lett; 2006 Dec 13; 410(1):25-30. PubMed ID: 17070994 [Abstract] [Full Text] [Related]
31. CEBPA polymorphisms and mutations in patients with acute myeloid leukemia, myelodysplastic syndrome, multiple myeloma and non-Hodgkin's lymphoma. Fuchs O, Provaznikova D, Kocova M, Kostecka A, Cvekova P, Neuwirtova R, Kobylka P, Cermak J, Brezinova J, Schwarz J, Markova J, Salaj P, Klamova H, Maaloufova J, Lemez P, Novakova L, Benesova K. Blood Cells Mol Dis; 2008 Dec 13; 40(3):401-5. PubMed ID: 18182175 [Abstract] [Full Text] [Related]
32. Inhibition of nitric oxide production by the carbazole compound LCY-2-CHO via blockade of activator protein-1 and CCAAT/enhancer-binding protein activation in microglia. Chang LC, Tsao LT, Chang CS, Chen CJ, Huang LJ, Kuo SC, Lin RH, Wang JP. Biochem Pharmacol; 2008 Aug 15; 76(4):507-19. PubMed ID: 18586011 [Abstract] [Full Text] [Related]
33. Proteomic identification of glucocorticoid receptor interacting proteins. Hedman E, Widén C, Asadi A, Dinnetz I, Schröder WP, Gustafsson JA, Wikström AC. Proteomics; 2006 May 15; 6(10):3114-26. PubMed ID: 16619302 [Abstract] [Full Text] [Related]
34. Elevated PIN1 expression by C/EBPalpha-p30 blocks C/EBPalpha-induced granulocytic differentiation through c-Jun in AML. Pulikkan JA, Dengler V, Peer Zada AA, Kawasaki A, Geletu M, Pasalic Z, Bohlander SK, Ryo A, Tenen DG, Behre G. Leukemia; 2010 May 15; 24(5):914-23. PubMed ID: 20376080 [Abstract] [Full Text] [Related]